WAVE Life Sciences Ltd.
WVE
$5.74
-$0.34-5.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 65.37M | 71.80M | 42.73M | 109.23M | 93.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.37M | 71.80M | 42.73M | 109.23M | 93.95M |
| Cost of Revenue | 197.42M | 189.60M | 182.78M | 174.61M | 169.93M |
| Gross Profit | -132.05M | -117.80M | -140.05M | -65.38M | -75.99M |
| SG&A Expenses | 85.87M | 79.08M | 75.33M | 70.57M | 67.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 283.29M | 268.68M | 258.11M | 245.18M | 237.46M |
| Operating Income | -217.92M | -196.88M | -215.38M | -135.95M | -143.51M |
| Income Before Tax | -202.47M | -183.59M | -204.38M | -121.95M | -129.87M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -202.47 | -183.59 | -204.38 | -121.95 | -129.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -202.47M | -183.59M | -204.38M | -121.95M | -129.87M |
| EBIT | -217.92M | -196.88M | -215.38M | -135.95M | -143.51M |
| EBITDA | -214.52M | -193.47M | -211.94M | -132.45M | -139.92M |
| EPS Basic | -1.09 | -1.05 | -1.21 | -0.74 | -0.88 |
| Normalized Basic EPS | -0.68 | -0.66 | -0.76 | -0.46 | -0.55 |
| EPS Diluted | -1.09 | -1.05 | -1.21 | -0.75 | -0.89 |
| Normalized Diluted EPS | -0.68 | -0.66 | -0.76 | -0.47 | -0.56 |
| Average Basic Shares Outstanding | 752.07M | 712.05M | 674.45M | 655.79M | 620.61M |
| Average Diluted Shares Outstanding | 752.07M | 712.05M | 674.45M | 666.59M | 631.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |